Clinical Trial Update: A Study to Evaluate the Safety of QCZ484 in Healthy and Mild Hypertensive Subjects [Phase 1]

View source ↗

Summary

Phase 1 safety study update for QCZ484 conducted in healthy volunteers and individuals with mild hypertension. The trial was completed under the sponsorship of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• QCZ484

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Mild Hypertension | Phase 1 | Status: COMPLETED